Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany: An Analysis of Sickness Funds. - Suppr | 超能文献

Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany: An Analysis of Sickness Funds.

作者信息

Tomeczkowski J, Leisten M K, Metin H, Khuen C, Fleischmann J, Tapprich C

机构信息

Janssen-Cilag GmbH, Neuss, Germany.

Janssen-Cilag Germany, Neuss, Germany.

出版信息

Value Health. 2014 Nov;17(7):A524. doi: 10.1016/j.jval.2014.08.1645. Epub 2014 Oct 26.

DOI:10.1016/j.jval.2014.08.1645

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany: An Analysis of Sickness Funds.

Value Health. 2014 Nov;17(7):A524. doi: 10.1016/j.jval.2014.08.1645. Epub 2014 Oct 26.

2

The prevalence of ocular disease in chronic lymphocytic leukaemia.慢性淋巴细胞白血病患者眼部疾病的患病率。

Eye (Lond). 2003 Jan;17(1):27-30. doi: 10.1038/sj.eye.6700277.

3

Flow cytometric identification of 76 patients with biclonal disease among 5523 patients with chronic lymphocytic leukaemia (B-CLL) and its genetic characterization.流式细胞术鉴定 5523 例慢性淋巴细胞白血病（B-CLL）患者中的 76 例双克隆疾病及其遗传特征。

Br J Haematol. 2014 Feb;164(4):565-9. doi: 10.1111/bjh.12652. Epub 2013 Nov 14.

4

Angiogenic factors in chronic lymphocytic leukaemia (CLL): Where do we stand?慢性淋巴细胞白血病（CLL）中的血管生成因子：我们处于什么位置？

Crit Rev Oncol Hematol. 2015 Mar;93(3):225-36. doi: 10.1016/j.critrevonc.2014.10.007. Epub 2014 Oct 12.

5

LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma.淋巴样增强因子1：一种用于诊断慢性淋巴细胞性B细胞白血病/小淋巴细胞性B细胞淋巴瘤的高度特异性标志物。

J Clin Pathol. 2015 Jun;68(6):473-8. doi: 10.1136/jclinpath-2015-202862. Epub 2015 Feb 24.

6

Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia.靶向重测序分析慢性淋巴细胞白血病中复发性基因突变的克隆组成。

Br J Haematol. 2013 Nov;163(4):496-500. doi: 10.1111/bjh.12539. Epub 2013 Aug 27.

7

The clinical and epidemiological burden of chronic lymphocytic leukaemia.慢性淋巴细胞白血病的临床及流行病学负担

Eur J Cancer Care (Engl). 2004 Jul;13(3):279-87. doi: 10.1111/j.1365-2354.2004.00489.x.

8

Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia.散发（非家族性）慢性淋巴细胞白血病患者一级亲属中的单克隆 B 细胞淋巴细胞增多症。

Br J Haematol. 2009 Nov;147(3):339-46. doi: 10.1111/j.1365-2141.2009.07861.x. Epub 2009 Aug 25.

9

Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia.慢性淋巴细胞白血病和幼淋巴细胞白血病中 BRAF V600E 突变的发生率。

Leuk Res. 2012 Apr;36(4):483-4. doi: 10.1016/j.leukres.2011.12.015. Epub 2012 Jan 9.

10

Disease burden of chronic lymphocytic leukaemia within the European Union.欧盟范围内慢性淋巴细胞白血病的疾病负担。

Eur J Haematol. 2008 Oct;81(4):253-8. doi: 10.1111/j.1600-0609.2008.01114.x. Epub 2008 Jul 8.

引用本文的文献

1

Demographic pattern of chronic lymphocytic leukemia in a tertiary hospital in Calabar, South-South Nigeria.尼日利亚西南部卡拉巴尔一家三级医院慢性淋巴细胞白血病的人口统计学模式

Ann Afr Med. 2020 Jul-Sep;19(3):203-206. doi: 10.4103/aam.aam_60_19.

2

Presenting features and treatment outcomes of chronic lymphocytic leukaemia in a resource poor Southern Nigeria.尼日利亚南部资源匮乏地区慢性淋巴细胞白血病的临床表现及治疗结果

Malawi Med J. 2019 Jun;31(2):144-149. doi: 10.4314/mmj.v31i2.7.